Novel Therapy for Treating Glaucoma
Controlled release dosage formulations for the delivery of active agents, especially for treatment of eye diseases or disorders, such as glaucoma, have been developed. These provide release of the active agent, such as ECA or a derivative thereof, for an effective period of time.
Interested in this Technology?
Submit your interest below.